Your PMS Is Real. Your PMDD Is Real. And So Are The Options.

To understand premenstrual symptoms, you need to understand what your hormones are doing in the second half of your cycle.

The menstrual cycle is the rhythm your hormonal system has run on since puberty: a tightly coordinated conversation between your brain and your ovaries that repeats itself month after month. PMS and PMDD, in essence, are what happen when the body responds to the natural fall in hormones when this conversation ends, at the end of your cycle. So before we can understand what is happening, we need to understand the usual rhythm first.

Let me introduce you to the menstrual cycle. Your monthly reminder that we are the ones carrying the human race forward, whether we asked to or not.

The cycle has two halves: a build-up to ovulation called the follicular phase, and a waiting period after ovulation called the luteal phase, when the body holds steady to see whether a pregnancy is beginning.

A less textbook version? Think of the menstrual cycle as preparing a guest room for a notoriously flaky friend. The first half is all preparation. Oestrogen rises, the lining thickens, an egg readies itself for ovulation. You put fresh linen on the bed, plump the pillows, place fresh flowers on the nightstand. The second half is the wait. If she turns up, the room is all ready for her stay (biologically speaking, you’re pregnant). More often than not, she sends a late text and is a no-show. You strip the bed, toss the wilted flowers, and the cycle begins all over again.

Day one of the cycle is the first day of your period. In hormonal terms, this is the body saying: not pregnant this month, time to start again.

Your pituitary gland, a small gland at the base of the brain, sends a hormonal signal called FSH, or follicle-stimulating hormone, to your ovaries. Its job is to encourage a group of follicles to start growing. Follicles are small fluid-filled sacs in the ovaries, and each one contains an immature egg.

These follicles now enter a kind of quiet competition. One follicle grows faster than the others and becomes the dominant follicle which is most likely to release an egg that cycle.

As this dominant follicle grows, it produces oestrogen. Oestrogen builds up the lining of the uterus, getting it ready in case a pregnancy needs to settle in.

Around the middle of the cycle, once oestrogen has risen high enough, the pituitary sends another signal. This one is called LH, or luteinising hormone.

LH is a trigger message telling the dominant follicle it’s show time, time to rupture and release its egg.

And ta da. Ovulation.

After ovulation, the empty follicle does not just disappear. It transforms into a structure called the corpus luteum, kind of like the follicle’s second act.

The corpus luteum sits in the ovary for the next 12 to 14 days and produces progesterone. Progesterone’s job is to hold the uterine lining steady and support an early pregnancy if that was on the menu that month.

If pregnancy does not occur, the corpus luteum breaks down. Progesterone levels fall. The uterine lining becomes unstable and eventually sheds.

Enter: your period.

And the cycle begins again.

Tap the diagram to enlarge, then drag to explore

If you are in the clinically significant range, the next question is what to do about it. Management starts with the foundations and builds from there: lifestyle and tracking first, then targeted strategies, then medication if needed.

The order is deliberate, not delaying tactics. The foundations shift the picture for many women, and skipping them often means missing the easiest gains. The tracking matters because PMS is unusually hard to treat without first knowing your own pattern. Symptoms rise and fall with the cycle, so a good week after a bad one is not proof anything has helped. Two or three months of tracking gives you the picture you need to make changes that actually work.

Nutrition, movement, sleep, stress management, and connection are not optional extras in PMS. They are the platform on which everything else sits, and they have real, well-evidenced effects on symptom severity. We cover these in detail in a separate guide.

We know how this lands. “Eat better, sleep more, exercise, manage your stress” is advice every woman has been given a hundred times, often as a substitute for being properly listened to. We get the eye-roll. And yes, doing it is harder than saying it. But the evidence really is on the side of the foundations. In many cases they are as effective as, or more effective than, anything we can prescribe. If we could bottle a Mediterranean diet, eight hours of sleep, two resistance sessions, and 50K steps a week, we would. Until then, we are stuck with doing the work. But it is worth doing, and we will help you get started.

Alcohol is metabolised more slowly in the luteal phase and tends to amplify mood symptoms, sleep disruption, and the next-morning anxiety some women already get the week before their period. Caffeine is similar. Neither needs to be eliminated, but they are worth noticing as variables you can adjust. Aerobic exercise has the strongest evidence of any single lifestyle change for reducing PMS symptom severity.

The luteal phase is the window where sleep matters most, and where it is also hardest to come by. As progesterone and ALLO fall in the days before your period, the brain’s calming system loses one of its main inputs, and sleep is one of the first things to suffer.

The practical move is to give sleep more runway in this window than you would the rest of the month. Earlier wind-down. Earlier lights out. Less alcohol, which is a known disruptor of luteal-phase sleep specifically. A cooler bedroom helps too, because progesterone raises core body temperature, and the warmth contributes to the restlessness many women describe in the days before their period. These are small adjustments that recognise the brain is working with less of its own calming chemistry, and giving it more external help to compensate.

Lifestyle change takes more effort, more time, and more patience than a prescription. In many cases, it is far more powerful.

If you know your symptoms cluster in a predictable window, the practical question becomes what you can adjust in that window to make it easier. For some women, this means front-loading social commitments to the first half of the cycle. For others, it means letting the people you live and work with know what week you are in, so you are not the only person carrying it. For others still, it means planning more sleep, more movement, fewer late nights, and a quieter week of work where possible.

This is not about organising your life around your cycle. It is about recognising the cycle exists, respecting your biology and sensitivities, and making small adjustments where you can. Many women find that tracking alone shifts the experience, because what used to be an unexplained week of feeling awful becomes a recognisable, predictable, manageable pattern.

The supplement market aimed at women with PMS is enormous, and the quality of evidence behind it varies wildly. Supplements are not held to the same regulatory standard as prescription medications, the advertising rules they sit under are far looser, and the industry is driven by profit rather than evidence. The combination means a product can be widely sold, heavily marketed, and confidently recommended without having had to prove it does anything at all. The cost of that, for women, is not just money. It is hope and time spent on things that were never going to work, when both could have gone toward something that does.

This is not to say there are no good options. The strongest evidence sits with replacing iron, B12, and vitamin D in women who are deficient (more common than most realise).

Beyond replacing what is deficient, the natural world offers a small number of options with reasonable evidence behind them, and a much larger number that have been heavily marketed without earning it. The dose ranges below come from the studies that found a real effect. Doses can vary by formulation, and the right dose for you is a conversation worth having with your doctor or pharmacist before starting anything new.

Supplement	What the evidence supports
VitexChasteberry, 20 to 40mg of standardised extract daily	Mood symptoms of PMS, particularly irritability and low mood.Worth knowingActs via the dopamine system rather than directly on the cycle. Takes around three months to see an effect.
SaffronAround 30mg per day	Mood symptoms, particularly low mood and irritability.Worth knowingActs on the same serotonin pathway as SSRIs, a useful one for PMS mood symptoms specifically. Effect often seen within two cycles.
Magnesium glycinate200 to 360mg per day	Physical symptoms, particularly cramping, headaches, breast tenderness. Some benefit for sleep and mood.Worth knowingMagnesium glycinate is the form used in most trials and is well-tolerated. Magnesium citrate is a reasonable alternative but can cause loose stools at higher doses. Magnesium oxide, often found in cheap supermarket multivitamins, is poorly absorbed and not what the evidence supports.
Vitamin B6Pyridoxine, 50 to 100mg per day	Mood symptoms, often paired with magnesium.Worth knowingDoses above 200mg per day for prolonged periods can cause nerve damage. Check your multivitamin label before adding more.
Calcium1000 to 1200mg per day	General PMS symptoms.Worth knowingThe original trials are decades old and have not been strongly replicated. The effect is modest, but the safety profile is good, so it is a reasonable option if you are not already getting this amount through diet and dairy.

Two things worth being clear on. Evening primrose oil has been recommended for PMS for decades despite the evidence consistently failing to support it, so it can be skipped without missing anything. And many of the “hormone balancing” supplement blends and protocols marketed at women with PMS have no good evidence behind them at all, despite the confident packaging. The names change over time, but at the time of writing this guide, the most popular include seed cycling, DIM (diindolylmethane), and “adrenal reset” or “cortisol detox” programs. None of these have evidence behind them for PMS or PMDD specifically. If a supplement or program is making confident claims about “balancing” your hormones, “supporting” your luteal phase, or “resetting” anything, it is worth checking the evidence so you can save your hope, money, and time.

CBT has a robust evidence base for PMS, particularly for the mood and irritability symptoms. The work is in two parts: noticing the cycle of thoughts that get amplified in the luteal phase (catastrophising, self-criticism, the conviction that the way you feel right now is the way you will always feel), and learning specific tools to interrupt those thought patterns before they take over the week. CBT for PMS is short, structured, and well-suited to the cycle, because the predictability of the luteal phase makes it possible to plan and rehearse.

CBT is widely available in Australia through Medicare-rebated psychology sessions on a Mental Health Care Plan, which your GP can prepare. For women whose PMS is mood-driven, CBT is one of the most useful first steps. It can be tried before medication, alongside medication, or in place of it, depending on where you sit on the spectrum and what you have already tried.

If the foundations and tracking and supplements and CBT have been worked through and PMS is still significantly affecting life, hormonal options are the next layer.

The logic is straightforward. If symptoms are driven by the natural rise and fall of progesterone, then suppressing the cycle, so there is no longer a rise and fall to react to, is one of the most reliable ways to reduce symptoms. The most common way we can do this is the COCP (combined oral contraceptive pill) used continuously, which means running packs back-to-back and skipping the placebo pills (often called sugar pills) so there is no hormonal drop.

The COCP suppresses ovulation, the corpus luteum no longer forms, and there is no natural progesterone surge and fall. For women whose PMS is driven by that fall, the COCP can substantially reduce symptoms. The evidence is strongest for COCPs containing drospirenone (such as Yaz and Yasmin), particularly when taken continuously (skipping the placebo week, so there is no withdrawal bleed).

Not all COCPs work equally well for PMS, and not all women feel well on any COCP. Some feel substantially better. Some feel no different. Some feel worse, particularly in their mood, in the early months. Like much of women’s health, the right answer is found by trial, observation, and review with a doctor who is paying attention.

For women who cannot or prefer not to take a COCP (because of migraine with aura, blood clot risk, blood pressure, smoking history, or breast cancer history), the POP (progestogen-only pill) is sometimes used. The evidence here is weaker. Some women do well, particularly the drospirenone-containing POP (Slinda) which more reliably suppresses ovulation. Others find a continuous progestogen worsens mood, for reasons we will come back to in Part Seven.

SSRIs (selective serotonin reuptake inhibitors) are usually thought of as a PMDD treatment, but they have a place in PMS too, particularly when symptoms are predominantly mood-driven and have not responded to the foundations, CBT, or hormonal options. SSRIs work differently in PMS and PMDD than they do in depression. The full mechanism is in Part Seven, but the short version is that they can be taken just in the luteal phase rather than continuously, and they begin working within days rather than weeks.

If your PMS is mood-heavy, persistent, and disruptive, an SSRI trial is reasonable even before formal PMDD criteria are met. This is a conversation worth having with your GP. If you do not have a GP, or yours is less familiar with this area, that is where we come in.

For most women with PMS, primary care management with a GP is enough. Gynaecology referral is appropriate when PMS is suspected to be coexisting with another gynaecological condition (endometriosis, adenomyosis, fibroids), when hormonal options have not worked or have been poorly tolerated, or when surgical options are being considered. Psychology referral is appropriate for CBT and for women whose PMS sits alongside a primary mood or anxiety disorder. Psychiatry referral is appropriate where PMS is coexisting with another psychiatric condition that is complicating treatment, or where first and second-line medications have not been effective.

PMDD is treatable. That sentence is worth pausing on, because many women with PMDD have spent years assuming nothing would help. The treatment pathway is well-established and most women respond well to one of the first or second-line approaches. The challenge is finding the right one, which sometimes takes more than one attempt.

There are two medical first-line treatment categories: SSRIs and hormonal options. Foundations and psychological strategies sit alongside both.

SSRIs are the first-line medical treatment for PMDD with the strongest evidence base. The evidence is for sertraline, fluoxetine, paroxetine, and escitalopram, all studied in PMDD specifically.

The mechanism is different from how SSRIs work in depression. In depression, SSRIs take four to six weeks to work because they are slowly building up serotonin signalling and triggering downstream changes in receptor sensitivity. In PMDD, SSRIs work within days, sometimes hours. They appear to work on the GABA-A system through a serotonin-mediated effect on allopregnanolone metabolism, rather than through the longer-term receptor changes that matter in depression.

If the receptor talk was a lot, the takeaway is this. SSRIs in PMDD work fast, often within days, and they work through a different pathway than they do in depression. Knowing they work differently is the bit that matters. The detail is for the curious.

Three dosing strategies are evidence-based.

Strategy	What it involves
Continuous dosing	The SSRI is taken every day, regardless of cycle phase.Worth knowingThe most reliable strategy if your luteal window is unpredictable, if you have any underlying anxiety or depression that the SSRI is also addressing, or if luteal-only dosing has not been enough.
Luteal-phase dosing	The SSRI is taken only in the second half of the cycle, typically starting at ovulation (around day 14) and continuing until day 1 of the period, then stopping.Worth knowingLower total medication exposure across the cycle. Requires reasonably predictable cycles to plan around. Not suitable if cycles are very irregular.
Step-up dosing	A lower dose of the SSRI is taken continuously through the cycle, with a planned dose increase during the luteal phase.Worth knowingA middle path between the two strategies above. Suits women who have some symptoms across the whole cycle but a clear worsening in the second half. Maintains some baseline coverage while increasing support when it is needed most. Needs reasonably predictable cycles to time the dose change.

Side effects are common in the first one to two weeks of starting an SSRI, particularly nausea, headache, sleep disruption, and reduced libido. For most women on continuous dosing, these settle within the first two weeks and do not return.

For women on luteal-phase dosing, the picture is slightly different. Because the SSRI is started and stopped each cycle, some initiation side effects can return at the start of each luteal phase. The good news is that for most women, they diminish across the first two or three cycles, as the body adapts more quickly each time. Mild nausea or sleep disruption on the first day or two of dosing in cycle one is normal. By cycle three, it is usually much less, or gone.

One side effect worth flagging separately is reduced libido, which can persist beyond the initiation window for some women, particularly on continuous dosing. Luteal-phase dosing tends to reduce this, with some evidence it also reduces the small risk of weight gain associated with continuous SSRI use, though the weight evidence is less well studied. If sexual side effects are persistent or troubling, raise it with your GP. There are options, including dose changes, drug switches, or moving from continuous to luteal-phase dosing.

Stopping an SSRI should always be done by tapering, not abruptly. This applies to luteal-phase dosing too once a regular pattern has been established, the once-a-cycle stop after day one of the period is itself a small taper, but if you decide to come off the SSRI altogether, do it with your GP’s guidance, not on your own.

The logic of hormonal treatment for PMDD is the same as for PMS, with one important difference. In PMS, partial cycle stabilisation is often enough. In PMDD, the goal is usually complete ovulation suppression, because any residual cycling can still trigger symptoms in women whose brains are highly sensitive.

Option	Clinical reasoning
Continuous COCP, drospirenone-containingYaz, Yasmin, Nextstellis	Suppresses ovulation completely. Drospirenone has additional anti-mineralocorticoid effects that may help with bloating and breast tenderness. Continuous dosing avoids the hormone-free week, which is when symptoms can re-emerge. Nextstellis is a newer option containing estetrol (a body-identical-style oestrogen) with drospirenone, but PMDD-specific evidence is still emerging.Worth knowingMost women with PMDD improve on a continuous drospirenone COCP. A significant minority experience mood worsening, particularly in the first one to three cycles. For some this settles, for others it does not, which is why close follow-up in the early months matters. Standard COCP contraindications apply (migraine with aura, blood clot risk, smoking over 35, blood pressure, breast cancer history).
Drospirenone-only POPSlinda	Suppresses ovulation in around 85% of cycles, far more reliably than older levonorgestrel-only POPs (which suppress ovulation in only 50 to 60%). Avoids the oestrogen component for women who cannot take it.Worth knowingPMDD-specific evidence is limited but the mechanism is biologically sound and the high ovulation suppression rate is what matters. Worth trialling for women who cannot take a COCP.
GnRH analogues with add-back MHT	Used in severe, treatment-resistant PMDD. Switches off ovulation at the brain level by suppressing the GnRH signals from the hypothalamus, which means the ovaries stop receiving the messages that drive ovulation. The result is a temporary, reversible chemical menopause. Low-dose oestrogen and progesterone are then added back in a stable, non-cycling way.Worth knowingReserved for women whose PMDD has not responded to first and second-line treatments. Effective when other options have not been. Requires careful monitoring and is the kind of treatment we manage at SWW directly when it is the right option.
Surgical removal of the ovaries, with MHT	The most definitive option. Removes the cycling entirely.Worth knowingReserved for severe, treatment-resistant PMDD where all other options have been tried. Irreversible. Surgical menopause has its own significant implications and requires careful, long-term hormone management. A last resort, not a first-line option.

CBT and DBT-style emotional regulation skills both have evidence in PMDD, and both work best as a layer alongside medication rather than instead of it.

The CBT work in PMDD focuses on the cognitive distortions that get most amplified in the luteal phase: the conviction that the way you feel right now is permanent, the catastrophising about relationships and work, and the self-criticism that often follows the irritability and anger. The structured nature of CBT works particularly well with the predictable nature of the cycle.

DBT (dialectical behaviour therapy) was originally developed for borderline personality disorder but its skills modules (distress tolerance, emotional regulation, interpersonal effectiveness) translate usefully to PMDD. Many women find the distress tolerance skills useful in acute moments of luteal-phase distress.

A psychologist with experience in cyclical mood disorders is worth seeking out. A Mental Health Care Plan from your GP gives you Medicare-rebated sessions to begin.

Everything in Part Four (sleep, alcohol, caffeine, movement, cycle-aware planning) applies in PMDD too. They are the foundations that ensure medical treatment can be as effective as it can be. Sleep in particular is worth protecting fiercely in the luteal phase, because the loss of allopregnanolone has already eroded the body’s natural sleep-promoting signal, and any additional sleep deprivation worsens every other symptom.

Specialist referral is appropriate when first-line options (SSRI plus or minus hormonal management) have not produced adequate response over three to four cycles, when GnRH analogue use is being considered, when surgical options are being considered, or when PMDD is coexisting with another psychiatric condition that is complicating treatment.

Gynaecology referral for hormonal or definitive surgical management. Psychiatry referral for medication strategy where SSRIs alone have not been enough, or where the diagnosis itself remains unclear. Many women benefit from both.